Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myeloid Leukemia
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This is an observational pilot study to examine the association between a patient's personality and adherence to tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• 18 years of age or older
• Diagnosed with chronic myeloid leukemia (CML) and in the chronic phase (CML-CP)
• Currently being treated with one of four cancer medications - imatinib, dasatinib, bosutinib, or nilotinib
• A patient at the UCI Chao Family Comprehensive Cancer Center (CFCCC), or
• A member of a patient support group organized by the CML Buster Foundation
• Do not meet any of the criteria listed under Exclusion Requirements
Locations
United States
California
Chao Family Comprehensive Cancer Center University of California, Irvine
RECRUITING
Orange
Contact Information
Primary
Chao Family Comprehensive Cancer Center University of California, Irvine
ucstudy@uci.edu
1-877-827-8839
Backup
University of California Irvine Medical
Time Frame
Start Date: 2024-01-25
Estimated Completion Date: 2026-01
Participants
Target number of participants: 75
Treatments
Adult patients with CML in chronic phase (CML-CP)
Related Therapeutic Areas
Sponsors
Leads: University of California, Irvine